The Hidden Costs of Non-Reporting Chronic Conditions in the US Workforce
A recent national poll conducted by Harvard T.H. Chan School of Public Health and the de Beaumont Foundation revealed the considerable impact of chronic illnesses on the United States workforce.
The poll, which was conducted among a nationally representative sample of 1,010 part-time and full-time working individuals, found that more than half of U.S. employees (58%) have physical chronic health issues such as hypertension, heart disease, diabetes, or asthma. This worrying statistic underscores the importance of improved workplace support systems.
Despite the prevalence of chronic diseases, most employees (60%) have not formally revealed them to their employers. Many individuals feel stigmatised because of their conditions, which can have a significant impact on their health and productivity.
This stigma affects not just individual employees but also the healthcare system and the economy in ways that are not visible.
Nondisclosure of chronic illnesses has far-reaching implications. More than one-third of employees with chronic diseases (36%) have skipped or postponed medical appointments to avoid interfering with work.
This behaviour not only exacerbates their health difficulties; it also increases long-term healthcare costs. When employees postpone treatment, their diseases can deteriorate, resulting in more serious health issues that necessitate more comprehensive and costly procedures.
Furthermore, the poll found that nearly half of employees with chronic conditions felt unable to take time off work (49%) or take a break at work (49%) due to their conditions. This inability to manage their health efficiently during work hours can result in lower productivity and higher absenteeism. This places additional strain on the healthcare system because employees may require more regular and urgent medical attention.
The poll also found that one-third of employees with chronic health disorders (33%) missed out on opportunities for increased hours or projects, while 25% missed out on prospects for advancement.
This not only has an impact on individual professional advancement but also leads to a loss of prospective economic contributions. Employees are unable to attain their full potential due to mismanaged chronic diseases, which influence the country's overall productivity and economic production.
The findings show that businesses play an important role in assisting employees with chronic diseases. Less than half of all U.S. workers think their present company is extremely supportive of critical actions that help employees to regulate their circumstances, such as taking breaks (44%) or taking paid time off (44%).
Employers should take proactive steps to establish a more supportive work environment by providing flexible scheduling, remote work choices, and ensuring that employees can access critical healthcare services without fear of stigma.
Brian Castrucci, president and CEO of the De Beaumont Foundation, emphasised that helping employees manage chronic conditions not only benefits their health but also allows firms to differentiate themselves, increase retention, and minimise absenteeism. Employers can assist in decreasing the hidden costs of chronic diseases by creating a supportive workplace environment, resulting in a healthier, more productive workforce.
Non-disclosure of chronic diseases in the US workforce has serious consequences for both individual health and the overall healthcare system. The stigma associated with these disorders causes delays in treatment, wasted opportunities, and higher healthcare expenses. Employers have a unique opportunity to address this issue by building supportive work cultures that encourage disclosure and make reasonable modifications.
This allows them to assist in decreasing the hidden expenses of chronic diseases while also contributing to a healthier, more productive staff. The survey results highlight the urgent need for a more comprehensive and sympathetic approach to addressing chronic diseases in the workplace.